BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28351524)

  • 1. G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.
    Luo CW; Wang JY; Hung WC; Peng G; Tsai YL; Chang TM; Chai CY; Lin CH; Pan MR
    Radiother Oncol; 2017 Sep; 124(3):395-402. PubMed ID: 28351524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G9a coordinates with the RPA complex to promote DNA damage repair and cell survival.
    Yang Q; Zhu Q; Lu X; Du Y; Cao L; Shen C; Hou T; Li M; Li Z; Liu C; Wu D; Xu X; Wang L; Wang H; Zhao Y; Yang Y; Zhu WG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6054-E6063. PubMed ID: 28698370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells.
    Tao H; Li H; Su Y; Feng D; Wang X; Zhang C; Ma H; Hu Q
    Mol Cell Biochem; 2014 Sep; 394(1-2):23-30. PubMed ID: 24833465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
    Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
    Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice.
    Weng D; Jin X; Qin S; Lan X; Chen C; Sun X; She X; Dong C; An R
    Oncotarget; 2017 Jul; 8(27):44004-44014. PubMed ID: 28430648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
    Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.
    Jao SW; Chen SF; Lin YS; Chang YC; Lee TY; Wu CC; Jin JS; Nieh S
    Ann Surg Oncol; 2012 Oct; 19(11):3432-40. PubMed ID: 22739652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
    Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
    Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
    Yu X; Mi L; Dong J; Zou J
    BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
    Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.